Oxford Biomedica Regulatory News (OXB)

1

Issuer

Oxford BioMedica PLC

2

Reason for notification

Notification relates to DTR 3.1.2R

3

Name of PDMR

Martin Diggle

4

Connected person

Notification relates to following connected persons:

Vulpes Testudo Fund

5

Notification in respect of

Notification in respect of holdings of persons in 4 above

6

Description of shares

Oxford BioMedica PLC ordinary shares of 1p each

7

Name of registered shareholders and number of shares

Vulpes Life Sciences Fund - 549,932,000 shares

Vulpes Testudo Fund - 33,333,333 shares

8

Nature of transaction

Acquisition and Disposal

9

Number of shares acquired

Vulpes Testudo Fund - 660,000 shares

10

Percentage of issued class acquired

Vulpes Testudo Fund- 0.02%

11

Shares disposed

Vulpes Testudo Fund - 658,899

12

Percentage of issued class disposed

Vulpes Testudo Fund - 0.02%

13/14

Price per share of transactions, and date

Vulpes Testudo Fund

Sold 658,899 shares @ £0.1003, 13 Jan 2017

Bought 660,000 shares @ £0.089, 13 Jan 2017

15

Total holding following notification and total percentage holding following notification

Vulpes Life Sciences Fund - 549,932,000 shares

17.8%

Vulpes Testudo Fund - 33,334,434 shares

1.1%

16

Date issuer informed

14 July 2017

23

Any additional information

None

24

Contact name and telephone number

T. Watts, Chief Financial Officer

Oxford BioMedica

+44 (0)1865 783000